Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Influenza neuraminidase
View through CrossRef
Please cite this paper as: Air. (2012) Influenza neuraminidase. Influenza and Other Respiratory Viruses 6(4), 245–256.Influenza neuraminidase is the target of two licensed antivirals that have been very successful, with several more in development. However, neuraminidase has been largely ignored as a vaccine target despite evidence that inclusion of neuraminidase in the subunit vaccine gives increased protection. This article describes current knowledge on the structure, enzyme activity, and antigenic significance of neuraminidase.
Title: Influenza neuraminidase
Description:
Please cite this paper as: Air.
(2012) Influenza neuraminidase.
Influenza and Other Respiratory Viruses 6(4), 245–256.
Influenza neuraminidase is the target of two licensed antivirals that have been very successful, with several more in development.
However, neuraminidase has been largely ignored as a vaccine target despite evidence that inclusion of neuraminidase in the subunit vaccine gives increased protection.
This article describes current knowledge on the structure, enzyme activity, and antigenic significance of neuraminidase.
Related Results
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic
Please cite this paper as: Borders‐Hemphill and Mosholder (2012) U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic. Influenza and...
Amino Acid Substitutions Analysis of the Putative Epitopes of Neuraminidase Protein from Influenza A H1N1 Virus
Amino Acid Substitutions Analysis of the Putative Epitopes of Neuraminidase Protein from Influenza A H1N1 Virus
Objective: This study verified whether the neuraminidase protein of Influenza A H1N1 virus sequence has modified from 2009–2017 and its impact on the 2018 Brazilian vaccine. Method...
A severe 2017 influenza season dominated by influenza A(H3N2), Victoria, Australia
A severe 2017 influenza season dominated by influenza A(H3N2), Victoria, Australia
Surveillance for influenza-like illness (ILI) and laboratory-confirmed influenza in Victoria, Australia is undertaken jointly by the Victorian Infectious Diseases Reference Laborat...
Study on the Interaction between Silibinin and Neuraminidase
Study on the Interaction between Silibinin and Neuraminidase
Background:
Neuraminidase is a pathogenic protein of the avian influenza virus. Previous studies
have shown that silibinin has the potential to inhibit neuraminidase activity.
Ob...
Comparative characteristics of clinical, laboratory and instrumental indicators in children with seasonal influenza depending on the virus strain
Comparative characteristics of clinical, laboratory and instrumental indicators in children with seasonal influenza depending on the virus strain
Introduction. According to the literature, it is known that clinical signs and symptoms of influenza may differ depending on age, the state of the human immune system, the serot...
Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010‐2016
Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010‐2016
BackgroundEstimating the national burden of influenza disease is challenging. We aimed to estimate the disease burden of seasonal influenza in Spain, at the primary care and hospit...
Progress of Influenza Viruses and Inhibitors
Progress of Influenza Viruses and Inhibitors
Influenza is an acute respiratory disease caused by influenza viruses. It has the
characteristics of fast transmission and strong infectivity, and it does great harm to human
healt...
Specific and Nonspecific Effects of Influenza Vaccines
Specific and Nonspecific Effects of Influenza Vaccines
With the introduction of the influenza vaccine in the official immunization schedule of most countries, several data regarding the efficacy, tolerability, and safety of influenza i...